LivaNova PLC
LivaNova PLC (LIVN) Financial Performance & Income Statement Overview
Analyze LivaNova PLC (LIVN) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
LivaNova PLC (LIVN) Income Statement & Financial Overview
Explore comprehensive income reports for LivaNova PLC LIVN, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $316.86M | $321.80M | $318.12M | $318.57M |
| Cost of Revenue | $96.08M | $102.48M | $92.86M | $98.21M |
| Gross Profit | $220.78M | $219.30M | $225.26M | $220.37M |
| Gross Profit Ratio | $0.70 | $0.68 | $0.71 | $0.69 |
| R&D Expenses | $37.88M | $43.31M | $48.80M | $44.74M |
| SG&A Expenses | $133.67M | $135.62M | $131.66M | $129.12M |
| Operating Expenses | $172.16M | $182.33M | $189.65M | $173.85M |
| Total Costs & Expenses | $268.24M | $289.91M | $282.50M | $272.06M |
| Interest Income | $6.44M | $8.58M | $7.14M | $7.34M |
| Interest Expense | $15.29M | $15.77M | $15.88M | $15.53M |
| Depreciation & Amortization | $0.00 | $12.58M | $13.13M | $12.29M |
| EBITDA | -$285.69M | $84.88M | $73.45M | $49.41M |
| EBITDA Ratio | -$0.90 | $0.26 | $0.23 | $0.16 |
| Operating Income | $48.62M | $37.02M | $35.62M | $46.51M |
| Operating Income Ratio | $0.15 | $0.12 | $0.11 | $0.15 |
| Other Income/Expenses (Net) | -$364.26M | $19.48M | $8.82M | -$18.58M |
| Income Before Tax | -$315.65M | $56.48M | $44.44M | $21.59M |
| Income Before Tax Ratio | -$1.00 | $0.18 | $0.14 | $0.07 |
| Income Tax Expense | $11.66M | $600000.00 | $11.53M | $5.23M |
| Net Income | -$327.32M | $55.89M | $32.95M | $16.33M |
| Net Income Ratio | -$1.03 | $0.17 | $0.10 | $0.05 |
| EPS | -$6.01 | $1.03 | $0.61 | $0.30 |
| Diluted EPS | -$6.01 | $1.02 | $0.60 | $0.30 |
| Weighted Avg Shares Outstanding | $54.42M | $54.40M | $54.35M | $54.24M |
| Weighted Avg Shares Outstanding (Diluted) | $54.42M | $54.70M | $54.59M | $54.59M |
The company's financials show resilient growth, with revenue advancing from $318.57M in Q2 2024 to $316.86M in Q1 2025. Gross profit remained healthy with margins at 70% in Q1 2025 compared to 69% in Q2 2024. Operating income hit $48.62M last quarter, sustaining a consistent 15% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$285.69M. Net income dropped to -$327.32M, while earnings per share reached -$6.01. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan